» Articles » PMID: 38385965

Mapping the Core Senescence Phenotype of Primary Human Colon Fibroblasts

Overview
Specialty Geriatrics
Date 2024 Feb 22
PMID 38385965
Authors
Affiliations
Soon will be listed here.
Abstract

Advanced age is the largest risk factor for many diseases and several types of cancer, including colorectal cancer (CRC). Senescent cells are known to accumulate with age in various tissues, where they can modulate the surrounding tissue microenvironment through their senescence associated secretory phenotype (SASP). Recently, we showed that there is an increased number of senescent cells in the colons of CRC patients and demonstrated that senescent fibroblasts and their SASP create microniches in the colon that are conducive to CRC onset and progression. However, the composition of the SASP is heterogenous and cell-specific, and the precise senescence profile of colon fibroblasts has not been well-defined. To generate a SASP atlas of human colon fibroblasts, we induced senescence in primary human colon fibroblasts using various methods and assessed the resulting transcriptome. Using RNASequencing and further validation by quantitative RT-PCR and Luminex assays, we define and validate a 'core senescent profile' that might play a significant role in shaping the colon microenvironment. We also performed KEGG analysis and GO analyses to identify key pathways and biological processes that are differentially regulated in colon fibroblast senescence. These studies provide insights into potential driver proteins involved in senescence-associated diseases, like CRC, which may lead to therapies to improve overall health in the elderly and to prevent CRC.

References
1.
Qi J, Sun H, Zhang Y, Wang Z, Xun Z, Li Z . Single-cell and spatial analysis reveal interaction of FAP fibroblasts and SPP1 macrophages in colorectal cancer. Nat Commun. 2022; 13(1):1742. PMC: 8976074. DOI: 10.1038/s41467-022-29366-6. View

2.
Tanaka T, Basisty N, Fantoni G, Candia J, Moore A, Biancotto A . Plasma proteomic biomarker signature of age predicts health and life span. Elife. 2020; 9. PMC: 7723412. DOI: 10.7554/eLife.61073. View

3.
Long X, Ye Y, Zhang L, Liu P, Yu W, Wei F . IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review). Int J Oncol. 2015; 48(1):5-12. DOI: 10.3892/ijo.2015.3234. View

4.
Jia Y, Zhang B, Zhang C, Kwong D, Chang Z, Li S . Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Esophageal Squamous Cell Carcinoma. Adv Sci (Weinh). 2023; 10(7):e2204565. PMC: 9982558. DOI: 10.1002/advs.202204565. View

5.
Bilusic M, Heery C, Collins J, Donahue R, Palena C, Madan R . Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors. J Immunother Cancer. 2019; 7(1):240. PMC: 6729083. DOI: 10.1186/s40425-019-0706-x. View